| Literature DB >> 31752379 |
Anna Lavecchia1, Matteo Chiara2, Caterina De Virgilio1, Caterina Manzari3, Rosa Monno4, Armando De Carlo5, Carlo Pazzani6, David Horner2,3, Graziano Pesole1, Antonio Placido3.
Abstract
Coagulase Negative Staphylococci (CoNS) are becoming increasingly recognized as an important cause of human and animal infections. Notwithstanding their clinical relevance, annotation of genes potentially involved in pathogenicity and/or antibiotic resistance in the CoNS species Staphylococcus arlettae (SAR) is currently very limited. In the current work we describe the genome of a novel methicillin resistant isolate of SAR, which we named Bari, and present a comprehensive analysis of predicted antibiotic resistance profiles and virulence determinants for all the 22 currently available SAR genomes. By comparing predicted antibiotic resistance and virulence-associated genes with those obtained from a manual selection of 148 bacterial strains belonging to 14 different species of staphylococci and to two "outgroup" species, Bacillus subtilis (BS) and Macrococcus caseoliticus (MC), we derived some interesting observations concerning the types and number of antibiotic resistance-related and virulence-like genes in SAR. Interestingly, almost 50% of the putative antibiotic resistance determinants identified in this work, which include the clinically relevant mec, van, and cls genes, were shared among all the SAR strains herein considered (Bari included). Moreover, comparison of predicted antibiotic resistance profiles suggest that SAR is closely related to well-known pathogenic Staphylococcus species, such as Staphylococcus aureus (SA) and Staphylococcus epidermidis (SE). A similar analysis of predicted virulence factors, revealed that several genes associated with pathogenesis (including, for example, ica, nuc, and ssp), which are commonly found in the genomes of pathogenic staphylococci such as Staphylococcus haemolyticus (SH) and Staphylococcus saprophyticus (SS), are observed also in the SAR strains for which a genomic sequence is available. All in all, we believe that the analyses presented in the current study, by providing a consistent and comprehensive annotation of virulence and antibiotic resistance-related genes in SAR, can constitute a valuable resource for the study of molecular mechanisms of opportunistic pathogenicity in this species.Entities:
Keywords: NGS sequencing; Staphylococcus arlettae; antibiotic resistance; coagulase negative staphylococci; draft genome; genomics; virulence
Year: 2019 PMID: 31752379 PMCID: PMC6920755 DOI: 10.3390/microorganisms7110580
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
In vitro antibiotic susceptibility of Staphylococcus arlettae (SAR) Bari and correlated predicted genes.
| Drug Class | Antibiotic Tested | In Vitro Susceptibility | Predicted Genes | |
|---|---|---|---|---|
| 1. | Oxacillin | R | ||
| 2. | Ampicillin | R | ||
| 3. | Cefoxitin | R | ||
| 4. | Ceftaroline | R | ||
| 5. | Imipenem | R | ||
| 6. | Penicillin | R | ||
| 7. | Lincosamide | Clindamycin | R | |
| 8. | Macrolide | Erythromycin | R | |
| 9. | - | Fosfomycin | R | |
| 10. | Fusidic Acid | Fusidic Acid | R | |
| 11. | Fluoroquinolone | Ciprofloxacin | S | |
| 12. | Moxifloxacin | S | ||
| 13. | Peptide | Daptomycin | S | |
| 14. | Glycopeptide | Teicoplanin | S | - |
| 15. | Vancomycin | S | ||
| 16. | Tetracycline | Tetracycline | S | |
| 17. | Tigecycline | S | ||
| 18. | Aminoglycoside | Gentamicin | S | |
| 19. | Oxazolidinone | Linezolid | S | |
| 20. | Diaminopyrimidine-Sulfonamide | Trimethoprim-Sulfamethoxazole | S |
|
| 21. | Monoxycarbolic Acid | Mupirocin | S | |
| 22. | Nitrofuran | Nitrofurantoin | S | - |
| 23. | Rifamycin | Rifampin | S |
Figure 1Pie chart of molecular determinants involved in antibiotic resistance mechanisms of SAR Bari draft genome.
Number of potential antibiotic resistance genes involved in antibiotic resistance mechanisms detected for each SAR strain after querying the Comprehensive Antibiotic Resistance Database (CARD).
| Strain * | N | Antibiotic Efflux | Antibiotic Inactivation | Antibiotic Target Alteration | Antibiotic Target Protection | Antibiotic Target Replacement |
|---|---|---|---|---|---|---|
| B | 227 | 117 | 39 | 57 | 10 | 4 |
| TS | 227 | 119 | 37 | 55 | 11 | 5 |
| B1 | 224 | 117 | 35 | 53 | 14 | 5 |
| B2 | 219 | 116 | 33 | 51 | 14 | 5 |
| B3 | 215 | 116 | 29 | 52 | 13 | 5 |
| AR1 | 219 | 113 | 32 | 59 | 9 | 6 |
| AR2 | 215 | 114 | 30 | 54 | 12 | 5 |
| AR3 | 220 | 114 | 33 | 56 | 12 | 5 |
| AR4 | 225 | 120 | 34 | 54 | 12 | 5 |
| AR5 | 216 | 113 | 32 | 54 | 12 | 5 |
| AR6 | 215 | 112 | 30 | 57 | 11 | 5 |
| AR7 | 220 | 113 | 32 | 58 | 12 | 5 |
| AR8 | 220 | 114 | 33 | 56 | 12 | 5 |
| AR9 | 223 | 116 | 35 | 56 | 11 | 5 |
| AR10 | 228 | 118 | 34 | 58 | 13 | 5 |
| AR11 | 225 | 119 | 32 | 57 | 12 | 5 |
| AR12 | 212 | 113 | 30 | 53 | 11 | 5 |
| AR13 | 219 | 112 | 31 | 59 | 12 | 5 |
| AR14 | 215 | 113 | 33 | 53 | 11 | 5 |
| AR15 | 234 | 125 | 35 | 57 | 12 | 5 |
| AR16 | 222 | 115 | 35 | 55 | 12 | 5 |
| AR17 | 217 | 114 | 35 | 55 | 8 | 5 |
| AR18 | 218 | 114 | 33 | 55 | 10 | 6 |
* B, SAR Bari strain; other abbreviations used are relative to the SAR genomes publicly available in the NCBI (see Table S1 for details).
Figure 2Network of antibiotic resistance determinants shared between all investigated species. Network was built by Cytoscape v. 3.7.2. The distance between species is proportional to the number of unique elements per species and connections among species. Orange diamond, SAR; yellow diamonds, Staphylococcus species (SA, SE, SAU, SSI, SSC, SCH, SC, SHY, SS, SAG, SK, SH, SF); light blue diamonds, outgroup species (BS, MC). The size of each diamond corresponds to the number of antibiotic resistance determinants per species. See Table S4 for details on the molecular elements of antibiotic resistance shared among the species in the dataset. Species abbreviations are in the Material and Methods Section (Section 2.4).
Figure 3Heatmap of virulence elements detected in the dataset. Clustering was based on comparative quantitative analysis of similar virulence elements identified within 148 genomes of the dataset. The different groups represent five different sets of virulence profiles. Color scale corresponds to the number of predicted genes associated to specific virulence element, from green (lowest) to red (highest). Note: Abbreviations used are relative to single strains (see Table S2 for details).
Virulence factors encoded by SAR Bari draft genome *.
| Vfclass | Virulence Factors | Related Genes | Hits |
|---|---|---|---|
| 1-Enzymes | Lipase |
| PROKKA_00412 |
| Serine V8 protease |
| PROKKA_02492 | |
| Thermonuclease |
| PROKKA_01673 | |
| 2-Immune evasion | Capsule | undetermined | PROKKA_00763; PROKKA_01266; PROKKA_01584; PROKKA_02340; PROKKA_02341; PROKKA_02342; PROKKA_02343; PROKKA_02439; PROKKA_02440; PROKKA_02511; |
| Capsule ( | - | PROKKA_02505 | |
| Polyglutamic acid capsule ( |
| PROKKA_01886 | |
|
| PROKKA_01887 | ||
| Polysaccharide capsule ( |
| PROKKA_01613 | |
| 3-Antiphagocytosis | Capsule ( |
| PROKKA_02504 |
| 4-Nutritional factor | Allantoin utilization ( | - | PROKKA_00370 |
| PROKKA_00367 | |||
| PROKKA_00364; PROKKA_00365 | |||
| 5-Serum resistance and immune evasion | LPS ( |
| PROKKA_02442 |
* VFanalyzer original output.
Virulence-factor genes predicted within SAR.
| Strains *. | N | Genes |
|---|---|---|
| B1; B2; B3; AR1; AR10; AR11; AR12; AR13; AR14; AR15; AR16; AR17; AR18; AR2; AR3; AR4; AR5; AR6; AR7; AR8; AR9; TS; B | 2 | Undetermined capsule, |
| B1; B2; B3; AR1; AR10; AR11; AR12; AR14; AR15; AR16; AR17; AR18; AR2; AR3; AR4; AR5; AR6; AR7; AR8; AR9; TS; B | 1 |
|
| B1; B2; B3; AR10; AR11; AR12; AR13; AR14; AR15; AR16; AR17; AR18; AR2; AR3; AR4; AR5; AR6; AR7; AR8; AR9; TS; B | 1 |
|
| B1; B2; B3; AR1; AR10; AR11; AR12; AR13; AR14; AR15; AR16; AR17; AR18; AR2; AR3; AR4; AR5; AR6; AR7; AR8; AR9; B | 3 |
|
| AR1; AR10; AR11; AR13; AR14; AR15; AR16; AR17; AR18; AR2; AR3; AR4; AR5; AR6; AR7; AR8; AR9; B | 1 |
|
| AR10; AR11; AR12; AR13; AR14; AR15; AR16; AR2; AR3; AR4; AR5; AR6; AR7; AR8; AR9 | 6 |
|
| B2; AR10; AR13; AR3; AR7; AR8; AR9 | 1 |
|
| B2; AR12; AR13; AR18; AR7; AR8 | 1 |
|
| AR12; AR13; AR7; AR8 | 2 |
|
| B1; B2; B3 | 1 |
|
| B2; AR12; AR8 | 5 |
|
| B2; AR13; AR8 | 2 |
|
| AR1; AR15; AR8 | 1 |
|
| AR12; AR13; AR8 | 1 |
|
| AR17; B | 1 |
|
| B1; AR17 | 2 |
|
| B2; AR8 | 1 |
|
| B2; AR12 | 1 |
|
| B2; AR13 | 1 |
|
| B3; B | 1 | Allantoin utilization |
| AR8 | 2 |
|
| AR12 | 1 |
|
| AR17 | 1 |
|
* B, SAR Bari strain; other abbreviations used are relative to the SAR genomes publicly available in the NCBI (see Table S1 for details).
Genes encoding virulence factors shared between SAR and other species in the dataset.
| Species * | N | Genes |
|---|---|---|
| BS; MC; SA; SAG; SAR; SAU; SC; SCH; SE; SF; SH; SHY; SK; SS; SSC; SSI | 1 |
|
| SAG; SAR; SAU; SC; SCH; SE; SF; SH; SHY; SK; SS; SSI | 1 |
|
| BS; SAG; SAR; SAU; SC; SCH; SE; SH; SHY; SK; SS; SSI | 2 |
|
| BS; MC; SAG; SAR; SC; SCH; SE; SF; SHY; SK; SS | 1 |
|
| SA; SAR; SC; SCH; SE; SF; SH; SK; SS | 1 |
|
| MC; SA; SAR; SC; SE; SK; SS; SSC; SSI | 1 |
|
| BS; MC; SAG; SAR; SCH; SF; SHY; SS; SSC | 1 |
|
| BS; SAR; SAU; SC; SF; SHY; SK; SS; SSI | 1 |
|
| SA; SAR; SC; SE; SK; SS; SSC; SSI | 1 |
|
| MC; SAG; SAR; SC; SH; SHY; SK; SSI | 1 |
|
| BS; SA; SAG; SAR; SE; SHY; SSI | 1 |
|
| SA; SAR; SC; SE; SK; SS; SSC | 1 |
|
| MC; SAR; SAU; SC; SF; SH; SSI | 1 |
|
| SA; SAG; SAR; SE; SHY; SSI | 3 |
|
| MC; SAG; SAR; SCH; SHY; SSC | 1 |
|
| BS; SAG; SAR; SHY; SK; SSI | 1 |
|
| MC; SAR; SC; SH; SHY; SSI | 1 |
|
| BS; SAR; SH; SHY; SK; SSI | 1 |
|
| SA; SAG; SAR; SE; SSI | 1 |
|
| SAR; SC; SHY; SSC; SSI | 1 |
|
| BS; MC; SAR; SF; SS | 1 |
|
| MC; SAR; SC; SSI | 1 |
|
| BS; MC; SAR; SSC | 1 |
|
| SA; SAR; SE | 1 |
|
| BS; SAR; SAU | 1 |
|
| BS; SAR; SK | 1 |
|
| BS; MC; SAR | 1 |
|
| SAR; SAU | 1 |
|
| SAR; SE | 1 |
|
| BS; SAR | 4 |
|
| SAR | 6 |
|
* Meanings of the abbreviations used are available in the Material and Methods (Section 2.4 Dataset). The complete list of all genes shared among all species in the dataset is available in Table S7.